Description

Algerika (Pregabalin) Hard Capsules 150 mg. №56

Ingredients:

Each hard capsule contains 150 mg of pregabalin.

Mechanism of Action:

Pregabalin binds to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing neurotransmitter release and modulating pain signaling pathways.

Pharmacological Properties:

Pregabalin exhibits anticonvulsant and analgesic properties by interacting with calcium channels in the CNS.

Indications for Use:

Algerika (pregabalin) is indicated for managing neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.

Contraindications:

Avoid Algerika (pregabalin) if allergic to pregabalin or any capsule ingredient. Contraindicated in patients with heart issues.

Side Effects:

Common side effects include dizziness, drowsiness, and weight gain. Caution advised when driving or operating machinery.

Usage Instructions:

Take as directed by healthcare provider. Typically oral administration with or without food. Do not exceed recommended dose.

Benefits Compared to Analogues:

Algerika has shown efficacy in managing neuropathic pain with a favorable side effect profile compared to other medications.

Suitable Patient Groups:

Recommended for adult patients with neuropathic pain conditions. Dosage adjustments may be needed for elderly individuals.

Storage Conditions and Shelf Life:

Store at room temperature away from moisture and heat. Check expiration date on packaging.

Packaging Description:

Each package contains 56 hard capsules of 150 mg pregabalin.

Clinical Evidence and Proven Effectiveness:

Clinical studies have shown the efficacy of pregabalin in reducing neuropathic pain and improving quality of life in patients with chronic pain conditions. For instance, a study in the Journal of Pain Research indicated significant pain reduction and improved sleep quality in fibromyalgia patients.